Next generation sequencing and the classical HLA loci in full heritage Pima Indians of Arizona: Defining the core HLA variation for North American Paleo-Indians.


Journal

Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 16 04 2019
revised: 10 10 2019
accepted: 11 10 2019
pubmed: 11 11 2019
medline: 28 3 2020
entrez: 11 11 2019
Statut: ppublish

Résumé

The Pima Indians of the Gila River Indian Community in Arizona have participated in a long-range study of type 2 diabetes mellitus since 1965 and have been the subject of HLA typing and population studies since the early days of serological assays. These data have been in numerous HLA workshops and conferences and have been the source of at least five novel alleles at the classical HLA loci. In recent time nearly the entire study group was subject to next generation sequencing by whole genome or exome technologies, which has allowed us to HLA type over 3000 full heritage persons with recently developed computer algorithms. We present here the results for the classical HLA Loci: HLA-A, B, C, DRA, DRB1, DRB3, DRB4, DRB5, DPA1, DPB1, DQA1, and DQB1 to the third field of resolution for synonymous alleles and type the likely four field resolution alleles from the subset of whole genome sequences. Allele frequencies, and haplotype frequencies at up to five loci, are presented as well as measures of population structure and heterozygosity. We define a core set of HLA variation that approximates the distribution for the Paleo-Indians and impute nine-locus, 4-field haplotypes that are expected to be common in full heritage peoples.

Identifiants

pubmed: 31706744
pii: S0198-8859(19)30302-7
doi: 10.1016/j.humimm.2019.10.002
pii:
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

955-965

Informations de copyright

Published by Elsevier Inc.

Auteurs

Robert C Williams (RC)

Phoenix Epidemiology and Clinical Research Branch, NIH, NIDDK, Phoenix, AZ 85014, United States. Electronic address: williamsr@mail.nih.gov.

William C Knowler (WC)

Phoenix Epidemiology and Clinical Research Branch, NIH, NIDDK, Phoenix, AZ 85014, United States.

Alan R Shuldiner (AR)

Regeneron Genetics Center, Tarrytown, NY 10591, United States.

Nehal Gosalia (N)

Regeneron Genetics Center, Tarrytown, NY 10591, United States.

Cristopher Van Hout (C)

Regeneron Genetics Center, Tarrytown, NY 10591, United States.
Regeneron Genetics Center, Tarrytown, NY 10591, United States.

Robert L Hanson (RL)

Phoenix Epidemiology and Clinical Research Branch, NIH, NIDDK, Phoenix, AZ 85014, United States.

Clifton Bogardus (C)

Phoenix Epidemiology and Clinical Research Branch, NIH, NIDDK, Phoenix, AZ 85014, United States.

Leslie J Baier (LJ)

Phoenix Epidemiology and Clinical Research Branch, NIH, NIDDK, Phoenix, AZ 85014, United States.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH